These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3788268)

  • 61. Confounding variables in neuroendocrine challenge tests: what we need to control for.
    Golden RN; Gilmore JH; Ekstrom RD; Leatherman M; Carson SW
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():210A-211A. PubMed ID: 1498815
    [No Abstract]   [Full Text] [Related]  

  • 62. The historical development of pharmacokinetics.
    Gladtke E
    Methods Find Exp Clin Pharmacol; 1986 Oct; 8(10):587-91. PubMed ID: 3784697
    [No Abstract]   [Full Text] [Related]  

  • 63. Potential and limitations of drug targeting: an overview.
    Gardner CR
    Biomaterials; 1985 May; 6(3):153-60. PubMed ID: 3890975
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The language of pharmacokinetics: an attempt to define terms (1)].
    Therapie; 1978; 33(6):699-711. PubMed ID: 746517
    [No Abstract]   [Full Text] [Related]  

  • 65. Scheele lecture. Pharmacokinetics: concepts, insights and applications.
    Rowland M
    Acta Pharm Suec; 1986; 23(3):173-90. PubMed ID: 3766162
    [No Abstract]   [Full Text] [Related]  

  • 66. Human pharmacokinetics.
    Bozler G
    Hum Genet Suppl; 1978; (1):13-7. PubMed ID: 285023
    [No Abstract]   [Full Text] [Related]  

  • 67. [Theoretical studies on interactions between pharmacon models and ionic receptor binding sites (author's transl)].
    Höltje HD
    Arch Pharm (Weinheim); 1978 Jan; 311(1):2-11. PubMed ID: 626563
    [No Abstract]   [Full Text] [Related]  

  • 68. Interactions of drug sof abuse: preface.
    Vessell ES; Braude MC
    Ann N Y Acad Sci; 1976; 281():VII-X. PubMed ID: 1071362
    [No Abstract]   [Full Text] [Related]  

  • 69. How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?
    MacKay D
    J Pharm Pharmacol; 1978 May; 30(5):312-3. PubMed ID: 26747
    [No Abstract]   [Full Text] [Related]  

  • 70. Quantification of receptor interactions using binding methods.
    Lazareno S
    J Recept Signal Transduct Res; 2001; 21(2-3):139-65. PubMed ID: 11757681
    [No Abstract]   [Full Text] [Related]  

  • 71. [New methodological aspects of experimental pharmacokinetics (author's transl)].
    Lesne M
    J Pharm Belg; 1977; 32(2):186-202. PubMed ID: 894479
    [No Abstract]   [Full Text] [Related]  

  • 72. Frequently cited references in contemporary pharmacokinetics.
    Boxenbaum H; Pivinski F
    Drug Metab Rev; 1984-1985; 15(7):1385-402. PubMed ID: 6398778
    [No Abstract]   [Full Text] [Related]  

  • 73. Letter: Renal contribution to drug biotransformation.
    Kamath BL; Levy G
    J Pharm Sci; 1974 Aug; 63(8):1342-3. PubMed ID: 4852916
    [No Abstract]   [Full Text] [Related]  

  • 74. Principles of agonism: undressing efficacy.
    Schwartz TW; IJzerman AP
    Trends Pharmacol Sci; 1998 Nov; 19(11):433-6. PubMed ID: 9850604
    [No Abstract]   [Full Text] [Related]  

  • 75. In consideration of active metabolites.
    Poynor WJ
    J Clin Pharmacol; 1987 Mar; 27(3):167-8. PubMed ID: 3680570
    [No Abstract]   [Full Text] [Related]  

  • 76. Theoretical treatment of events between the drug-receptor association and the effect.
    Gero A
    J Theor Biol; 1983 Sep; 104(2):249-59. PubMed ID: 6645557
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Radioactive-labeled pharmaceutical agents].
    Pleiss U
    Pharm Unserer Zeit; 2005; 34(6):514-9. PubMed ID: 16320640
    [No Abstract]   [Full Text] [Related]  

  • 78. Novel flow injection methods for drug-receptor interaction studies, based on probing cell metabolism.
    Lähdesmäki I; Ruzicka J; Ivaska A
    Analyst; 2000 Oct; 125(10):1889-95. PubMed ID: 11070559
    [No Abstract]   [Full Text] [Related]  

  • 79. Receptor-mediated endocytosis of macromolecular conjugates in selective drug delivery.
    Basu SK
    Biochem Pharmacol; 1990 Nov; 40(9):1941-6. PubMed ID: 2242027
    [No Abstract]   [Full Text] [Related]  

  • 80. Finding the "Magic".
    Amidon GL
    Mol Pharm; 2004 Jan; 1(1):1. PubMed ID: 15832495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.